Cargando…

New anti HCV drugs in the pipeline

Detalles Bibliográficos
Autor principal: Bourlière, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316049/
http://dx.doi.org/10.1186/1742-4690-7-S1-I24
_version_ 1782228334605762560
author Bourlière, Marc
author_facet Bourlière, Marc
author_sort Bourlière, Marc
collection PubMed
description
format Online
Article
Text
id pubmed-3316049
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33160492012-03-31 New anti HCV drugs in the pipeline Bourlière, Marc Retrovirology Invited Speaker Presentation BioMed Central 2010-05-11 /pmc/articles/PMC3316049/ http://dx.doi.org/10.1186/1742-4690-7-S1-I24 Text en Copyright ©2010 Bourlière; licensee BioMed Central Ltd.
spellingShingle Invited Speaker Presentation
Bourlière, Marc
New anti HCV drugs in the pipeline
title New anti HCV drugs in the pipeline
title_full New anti HCV drugs in the pipeline
title_fullStr New anti HCV drugs in the pipeline
title_full_unstemmed New anti HCV drugs in the pipeline
title_short New anti HCV drugs in the pipeline
title_sort new anti hcv drugs in the pipeline
topic Invited Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316049/
http://dx.doi.org/10.1186/1742-4690-7-S1-I24
work_keys_str_mv AT bourlieremarc newantihcvdrugsinthepipeline